Spero Therapeutics, Inc. (SPRO)

1.20 -0.01 (-0.83%) USD  |  NASDAQ  |  Aug 28, 16:00
1.20 0.00 (0.00%) After-Hours: 20:00
More

Spero Therapeutics Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for SPRO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2023. Start Trial.
Date Value
August 14, 2025 --
July 29, 2025 --
June 10, 2025 --
May 19, 2025 --
April 02, 2025 --
January 30, 2025 --
December 02, 2024 --
November 18, 2024 --
November 04, 2024 --
August 06, 2024 --
August 05, 2024 --
Date Value
May 16, 2024 --
May 15, 2024 --
April 04, 2024 --
March 18, 2024 --
March 14, 2024 --
March 13, 2024 --
February 23, 2024 --
January 03, 2024 --
January 02, 2024 --
November 17, 2023 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Inovio Pharmaceuticals, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Kura Oncology, Inc. Upgrade
Legend Biotech Corp. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade